FDA approves new cardiovascular drug based on study at U of A
Vericiguat, which was shown to reduce risk of cardiovascular death and heart failure, passes final regulatory hurdle in the United States
Read MoreVericiguat, which was shown to reduce risk of cardiovascular death and heart failure, passes final regulatory hurdle in the United States
Read MoreNew U of A research illustrates link between anthropogenic diet, human-like gut bacteria and poor health
Read MoreFor Khaled Barakat, a focus on teamwork and patient needs has led to breakthroughs in the search for cancer therapies, antivirals and safer drugs
Read MorePotential biomarker found that could help with optimal electrode placement in deep brain stimulation surgery
Read More$4-million endowed chair will focus on improving growth and yield of forests, informing industry management plans and educating the next generation of forestry professionals
Read More